|
US3992518A
(en)
|
1974-10-24 |
1976-11-16 |
G. D. Searle & Co. |
Method for making a microsealed delivery device
|
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
|
IE60901B1
(en)
|
1986-08-21 |
1994-08-24 |
Vestar Inc |
Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
|
|
US5635599A
(en)
|
1994-04-08 |
1997-06-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Fusion proteins comprising circularly permuted ligands
|
|
US5660848A
(en)
|
1994-11-02 |
1997-08-26 |
The Population Council, Center For Biomedical Research |
Subdermally implantable device
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
GB9524973D0
(en)
|
1995-12-06 |
1996-02-07 |
Lynxvale Ltd |
Viral vectors
|
|
ATE252372T1
(de)
|
1996-08-23 |
2003-11-15 |
Sequus Pharm Inc |
Liposome enthaltend cisplatin
|
|
JP2001503396A
(ja)
|
1996-10-11 |
2001-03-13 |
アルザ コーポレイション |
治療用リポソーム組成物および方法
|
|
US6056973A
(en)
|
1996-10-11 |
2000-05-02 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method of preparation
|
|
WO1999046392A1
(en)
|
1998-03-12 |
1999-09-16 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods and compositions of chemokine-tumor antigen fusion proteins as cancer vaccines
|
|
CN1736502A
(zh)
|
1999-03-03 |
2006-02-22 |
奥普蒂诺斯公司 |
鼻传送装置
|
|
CA2391080A1
(en)
|
1999-11-12 |
2001-05-25 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Erythropoietin forms with improved properties
|
|
US6808902B1
(en)
|
1999-11-12 |
2004-10-26 |
Amgen Inc. |
Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
|
|
EP1290170A2
(en)
|
2000-06-16 |
2003-03-12 |
Asterion Limited |
Binding agents: chimeric ligand/receptor proteins
|
|
IL155812A0
(en)
|
2000-12-07 |
2003-12-23 |
Lilly Co Eli |
Glp-1 fusion proteins
|
|
JP2004519230A
(ja)
|
2001-02-06 |
2004-07-02 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
低減された免疫原性を有する修飾されたインターロイキン−１受容体アンタゴニスト（ｉｌ−１ｒａ）
|
|
US7157277B2
(en)
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
|
IL147412A0
(en)
|
2001-12-31 |
2002-08-14 |
Yeda Res & Dev |
The use of il6r/il6 chimera in nerve cell regeneration
|
|
SI1499729T1
(sl)
|
2002-04-18 |
2011-11-30 |
Yeda Res & Dev |
Derivati encima ki inducira nf-kappab njihova priprava in uporaba
|
|
EP1517700B1
(en)
|
2002-04-22 |
2012-03-28 |
Recopharma AB |
Mucin fusion polypeptide vaccines, compositions and methods of use thereof
|
|
WO2004016740A2
(en)
|
2002-08-15 |
2004-02-26 |
Epitomics, Inc. |
Humanized rabbit antibodies
|
|
WO2004060911A2
(en)
|
2002-12-30 |
2004-07-22 |
Amgen Inc. |
Combination therapy with co-stimulatory factors
|
|
GB0315182D0
(en)
|
2003-06-28 |
2003-08-06 |
Asterion Ltd |
Cytokine variant polypeptides
|
|
AU2003259718A1
(en)
|
2003-08-07 |
2005-03-07 |
Epitomics, Inc. |
Methods for humanizing rabbit monoclonal antibodies
|
|
WO2005034863A2
(en)
|
2003-10-03 |
2005-04-21 |
Jarikuma Corporation |
Countermeasures against malaria
|
|
US8454963B2
(en)
|
2003-11-13 |
2013-06-04 |
Musc Foundation For Research Development |
Tissue targeted complement modulators
|
|
US7576183B2
(en)
|
2003-12-24 |
2009-08-18 |
Los Alamos National Security, Llc |
Structure-based receptor MIMICS targeted against bacterial superantigen toxins
|
|
PT1765397E
(pt)
*
|
2004-05-25 |
2013-02-04 |
Tactic Pharma Llc |
Anticorpos inibidores que se ligam ao complexo ativador plasminogénico do tipo uroquinasa (upa) e seu receptor (upar)
|
|
MX2007006214A
(es)
|
2004-11-24 |
2008-04-16 |
Therakine Ltd |
Un implante para suministro de farmaco intraocular.
|
|
CA2618791C
(en)
|
2005-08-12 |
2014-05-13 |
Riken |
Novel mucin-type glycoprotein and use thereof
|
|
EP1777294A1
(en)
|
2005-10-20 |
2007-04-25 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins
|
|
US20100016547A1
(en)
|
2005-11-30 |
2010-01-21 |
Takaomi Ito |
Glycosilated Peptide and Medicine Comprising It as an Effective Ingredient
|
|
DE602005015733D1
(de)
|
2005-12-02 |
2009-09-10 |
Apceth Gmbh & Co Kg |
Chemokin-Mucin Fusionsproteine mit einer GPI-Ankerdomäne und deren Verwendung als Tumor-Immun-Adjuvanzien oder in der Geweberegeneration
|
|
TW200813091A
(en)
|
2006-04-10 |
2008-03-16 |
Amgen Fremont Inc |
Targeted binding agents directed to uPAR and uses thereof
|
|
MX2009006398A
(es)
|
2006-12-12 |
2009-06-23 |
Biorexis Pharmaceutical Corp |
Genotecas de proteinas de fusion de transferrina.
|
|
US7816324B2
(en)
|
2007-03-13 |
2010-10-19 |
Board Of Regents, The University Of Texas System |
Composition and method for the treatment of diseases affected by a peptide receptor
|
|
ES2593484T3
(es)
|
2007-03-29 |
2016-12-09 |
Genmab A/S |
Anticuerpos biespecíficos y métodos de producción de los mismos
|
|
WO2008133857A1
(en)
*
|
2007-04-23 |
2008-11-06 |
Schering Corporation |
Anti-mdl-1 antibodies
|
|
WO2008133928A2
(en)
|
2007-04-27 |
2008-11-06 |
The Gi Company, Inc. |
Mucin glycoproteins and their use for treatment of epithelial lesions and mucin dependent disorders
|
|
KR20170036814A
(ko)
|
2007-05-21 |
2017-04-03 |
앨더바이오 홀딩스 엘엘씨 |
신규한 래빗 항체 인간화 방법 및 인간화된 래빗 항체
|
|
NZ599338A
(en)
|
2007-06-27 |
2013-11-29 |
Marinepolymer Tech Inc |
Complexes of il-15 and il-15ralpha and uses thereof
|
|
JP2010536341A
(ja)
|
2007-08-15 |
2010-12-02 |
アムニクス， インコーポレイテッド |
生物学的に活性なポリペプチドの特性を改変するための組成物および方法
|
|
EP2050759A1
(en)
|
2007-10-19 |
2009-04-22 |
CONARIS research institute AG |
Soluble gp 130 muteins with improved binding activity
|
|
MY152003A
(en)
|
2008-05-29 |
2014-08-15 |
Univ Leland Stanford Junior |
Cell line, system and method for optical control of secondary messengers
|
|
US8765669B2
(en)
|
2008-06-17 |
2014-07-01 |
Glytech, Inc. |
Glycosylated GLP-1 peptide
|
|
GB0815216D0
(en)
|
2008-08-21 |
2008-09-24 |
Asterion Ltd |
Interleukin
|
|
ES2610356T3
(es)
|
2009-02-03 |
2017-04-27 |
Amunix Operating Inc. |
Polipéptidos recombinantes extendidos y composiciones que comprenden los mismos
|
|
EP3028707A1
(en)
|
2009-05-01 |
2016-06-08 |
Ophthotech Corporation |
Methods for treating or preventing ophthalmological diseases
|
|
US9029509B2
(en)
|
2010-02-12 |
2015-05-12 |
The Regents Of The University Of California |
Antibodies and pharmaceutical compositions thereof which bind urokinase-type plasminogen activator receptor (uPAR)
|
|
WO2011103049A2
(en)
|
2010-02-16 |
2011-08-25 |
Immune Disease Institute, Inc. |
Method for screening receptors/ligands interactions
|
|
HUE049849T2
(hu)
|
2010-03-31 |
2020-10-28 |
Boehringer Ingelheim Int |
Anti-CD40 antitestek
|
|
EP2553101A4
(en)
|
2010-04-02 |
2013-09-04 |
Univ Rochester |
PROTEASE-ACTIVATED CYTOKINES
|
|
US9119869B2
(en)
|
2010-04-29 |
2015-09-01 |
Ronald J. Shebuski |
Mucin derived polypeptides
|
|
ES2952394T3
(es)
|
2010-07-29 |
2023-10-31 |
Buzzard Pharmaceuticals AB |
Antagonistas quiméricos del receptor IL-1 de tipo I
|
|
US8507222B2
(en)
|
2010-09-21 |
2013-08-13 |
Altor Bioscience Corporation |
Multimeric IL-15 soluble fusion molecules and methods of making and using same
|
|
US9511151B2
(en)
|
2010-11-12 |
2016-12-06 |
Uti Limited Partnership |
Compositions and methods for the prevention and treatment of cancer
|
|
EP2851429B1
(en)
|
2012-05-18 |
2019-07-24 |
Adda Biotech Inc. |
Protein and protein conjugate for diabetes treatment, and applications thereof
|
|
US9156897B2
(en)
|
2012-06-08 |
2015-10-13 |
Alkermes, Inc. |
Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide
|
|
US9499634B2
(en)
|
2012-06-25 |
2016-11-22 |
Zymeworks Inc. |
Process and methods for efficient manufacturing of highly pure asymmetric antibodies in mammalian cells
|
|
UY35148A
(es)
|
2012-11-21 |
2014-05-30 |
Amgen Inc |
Immunoglobulinas heterodiméricas
|
|
JP6385357B2
(ja)
|
2012-11-27 |
2018-09-05 |
アジュ ユニバーシティー インダストリー−アカデミック コーオペレイション ファウンデーションＡｊｏｕ Ｕｎｉｖｅｒｓｉｔｙ Ｉｎｄｕｓｔｒｙ−Ａｃａｄｅｍｉｃ Ｃｏｏｐｅｒａｔｉｏｎ Ｆｏｕｎｄａｔｉｏｎ |
抗体重鎖不変部位の異種二量体、高効率の形成を誘導するｃｈ３ドメイン変異体対、その作製方法および用途
|
|
MX387323B
(es)
*
|
2014-02-19 |
2025-03-18 |
Merck Patent Gmbh |
Il-12 dirigida al cáncer en combinación con il-7 para usarse en el tratamiento de cáncer.
|
|
WO2017062953A1
(en)
*
|
2015-10-10 |
2017-04-13 |
Intrexon Corporation |
Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12
|
|
EP3383908A1
(en)
*
|
2015-12-02 |
2018-10-10 |
Stsciences, Inc. |
Antibodies specific to glycosylated btla (b- and t- lymphocyte attenuator)
|
|
EP3464349A4
(en)
*
|
2016-05-23 |
2020-08-26 |
New York University |
COMPOSITIONS AND METHODS ASSOCIATED WITH ANTIBODIES TARGETING STAPHYLOCCAL LEUCOTOXINS
|
|
EP3555127B1
(en)
*
|
2016-12-16 |
2024-12-18 |
H. Lundbeck A/S |
Agents, uses and methods
|
|
US10364286B2
(en)
*
|
2016-12-22 |
2019-07-30 |
H. Lundbeck A/S |
Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation
|
|
JP2020530280A
(ja)
*
|
2017-07-03 |
2020-10-22 |
トルク セラピューティクス， インコーポレイテッド |
免疫刺激性融合分子およびその使用
|
|
CN110396133B
(zh)
|
2018-04-25 |
2021-07-23 |
免疫靶向有限公司 |
一种以白介素12为活性成分的融合蛋白型药物前体
|
|
AU2019355971B2
(en)
|
2018-10-03 |
2025-05-08 |
Xencor, Inc. |
IL-12 heterodimeric Fc-fusion proteins
|
|
BR112022007158A2
(pt)
|
2019-10-18 |
2022-07-05 |
Alkermes Pharma Ireland Ltd |
Agentes imunomodulatórios de il-2 em combinação com inibidores do ponto de verificação imunológico
|